Symbol="OCUP"
AssetType="Common Stock"
Name="Ocuphire Pharma Inc"
Description="Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of various eye disorders. The company is headquartered in Farmington Hills, Michigan."
CIK="1228627"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="15245 SHADY GROVE ROAD, SUITE 455, ROCKVILLE, MD, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="85485000"
EBITDA="18156000"
PERatio="4.435"
PEGRatio="None"
BookValue="1.797"
DividendPerShare="0"
DividendYield="0"
EPS="0.92"
RevenuePerShareTTM="2.176"
ProfitMargin="0.412"
OperatingMarginTTM="0.401"
ReturnOnAssetsTTM="0.37"
ReturnOnEquityTTM="0.714"
RevenueTTM="45273000"
GrossProfitTTM="-14584000"
DilutedEPSTTM="0.92"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="20.2"
TrailingPE="4.435"
ForwardPE="-"
PriceToSalesRatioTTM="92.17"
PriceToBookRatio="5.4"
EVToRevenue="52.97"
EVToEBITDA="-2.01"
Beta="0.101"
num_52WeekHigh="6.6"
num_52WeekLow="1.9"
num_50DayMovingAverage="4.041"
num_200DayMovingAverage="3.854"
SharesOutstanding="20952200"
DividendDate="2020-11-06"
ExDividendDate="None"
symbol="OCUP"
open="4.14"
high="4.19"
low="4.02"
price="4.08"
volume="101490.00"
latest_trading_day="2023-08-17"
previous_close="4.17"
change="-0.09"
change_percent="-2.1583%"
aroon_positive_momentum_days="61"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="61"
Volume_recent_avg="298274"
Change_recent_avg="-0.01"
Delta_recent_avg="0.34"
Variance_recent_avg="0.17"
Change_ratio_recent_avg="-0.29"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="61"
Aroon_momentum_negative="39"
image_negative_thumbnail_id_1="130"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0046.jpeg"
image_negative_thumbnail_id_2="1126"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0159.jpeg"
image_neutral_thumbnail_id_1="571"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0028.jpeg"
image_neutral_thumbnail_id_2="591"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0008.jpeg"
image_positive_thumbnail_id_1="979"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0141.jpeg"
image_positive_thumbnail_id_2="965"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0127.jpeg"
image_professor_thumbnail_id_1="1204"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
image_professor_thumbnail_id_2="1171"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
